Dragonfly Therapeutics
Dawn Wilson is an accomplished professional in clinical development operations with extensive experience in leadership roles at several biotechnology and pharmaceutical companies. Currently serving as Vice President of Clinical Development Operations at Dragonfly Therapeutics, Inc. since October 2024, Dawn previously held the position of Vice President of Clinical Operations & Data Management at Palleon Pharmaceuticals from May 2021 to October 2024. Additional roles include Vice President of Clinical Operations & Development at Cadent Therapeutics, Vice President of Clinical Operations at Albireo Pharma, and multiple leadership positions at Acceleron Pharma, where responsibilities included oversight of clinical operations and data management. Dawn began their career as Sr. Manager of Clinical Data Management at Idenix Pharmaceuticals. Dawn holds a Bachelor of Science in Mathematics and Biology from Tufts University.
This person is not in any teams
This person is not in any offices
Dragonfly Therapeutics
1 followers
Dragonfly Therapeutics is a discovery-stage company developing drugs to stimulate immune responses against cancer.